Legend Biotech (LEGN, $43.74) was a top loser over the last three months, falling -2 to $43.74 per share. A.I.dvisor analyzed 914 stocks in the Biotechnology Industry for the 3-month period ending April 30, 2024, and found that of them (5) exhibited an Uptrend while of them (4) demonstrated a Downtrend.